Telles Joao Paulo Mota, Yamaki Vitor Nagai, Yamashita Renata Gobbato, Solla Davi Jorge Fontoura, Paiva Wellingson Silva, Teixeira Manoel Jacobsen, Neville Iuri Santana
Department of Neurosurgery, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil.
Department of Neurology, University of São Paulo, Brazil.
Surg Neurol Int. 2020 Aug 21;11:258. doi: 10.25259/SNI_476_2020. eCollection 2020.
Patients with cancer are subject to all neurosurgical procedures of the general population, even if they are not directly caused by the tumor or its metastases. We sought to evaluate the impact of urgent neurosurgery on the survival of patients with cancer.
We included patients submitted to neurosurgeries not directly related to their tumors in a cancer center from 2009 to 2018. Primary endpoints were mortality in index hospitalization and overall survival.
We included 410 patients, 144 went through elective procedures, functional (26.4%) and debridement (73.6%) and 276 urgent neurosurgeries were performed: one hundred and sixty-three ventricular shunts (59%), and 113 intracranial hemorrhages (41%). Median age was 56 (IQR = 24), 142 (51.4%) of patients were metastatic, with 101 (36.6%) having brain metastasis. In 82 (33.7%) of the urgent surgeries, the patient died in the same admission. Urgent surgeries were associated with mortality in index hospitalization (OR 3.45, 95% CI 1.93-6.15), as well as non-primary brain tumors (OR 3.13, 95% CI 1.48-6.61). Median survival after urgent surgeries was 102 days, compared to 245 days in the control group (Log rank, < 0.01). Lower survival probability was associated with metastasis (HR 1.75, 95%CI 1.15-2.66) and urgent surgeries (HR 1.49, 95% CI 1.18-1.89). Within the urgent surgeries alone, metastasis predicted lower survival probability (HR 1.75, 95% CI 1.15-2.67).
Conditions that require urgent neurosurgery in patients with cancer have a very poor prognosis. We present concrete data on the magnitude of several factors that need to be taken into account when deciding whether or not to recommend surgery.
癌症患者会接受普通人群所接受的所有神经外科手术,即便这些手术并非由肿瘤或其转移灶直接导致。我们试图评估急诊神经外科手术对癌症患者生存的影响。
我们纳入了2009年至2018年期间在一家癌症中心接受与肿瘤无直接关联的神经外科手术的患者。主要终点为首次住院死亡率和总生存期。
我们纳入了410例患者,其中144例接受了择期手术,包括功能性手术(26.4%)和清创术(73.6%),并进行了276例急诊神经外科手术:163例脑室分流术(59%)和113例颅内出血手术(41%)。中位年龄为56岁(四分位间距 = 24),142例(51.4%)患者有转移,其中101例(36.6%)有脑转移。在82例(33.7%)急诊手术中,患者在同一次住院期间死亡。急诊手术与首次住院死亡率相关(比值比3.45,95%置信区间1.93 - 6.15),与非原发性脑肿瘤也相关(比值比3.13,95%置信区间1.48 - 6.61)。急诊手术后的中位生存期为102天,而对照组为245天(对数秩检验,P < 0.01)。较低的生存概率与转移(风险比1.75,95%置信区间1.15 - 2.66)和急诊手术(风险比1.49,95%置信区间1.18 - 1.89)相关。仅在急诊手术中,转移预示着较低的生存概率(风险比1.75,95%置信区间1.15 - 2.67)。
癌症患者需要急诊神经外科手术的情况预后非常差。我们提供了具体数据,说明了在决定是否推荐手术时需要考虑的几个因素的影响程度。